Val Kennedy

Val Kennedy is an experienced journalist specializing in business and healthcare reporting. Currently serving as a News Editor at Seeking Alpha since January 2022, Val focuses on IPO news. Concurrently, as a Contributing Writer for GoodRx since December 2020, Val covers Medicare, Medicaid, and public health issues. Previous experience includes a tenure as a Business Reporter at MarketWatch from May 2004 to May 2013, where Val specialized in biotechnology, pharmaceuticals, and green technology, while also being part of the breaking news team. Val began a career in journalism at Bridge News from 1998 to 2001, covering the biotechnology and technology sectors. Academic qualifications include a Master of Science from Boston University College of Communication and a Bachelor of Arts in Political Science and Government from Bates College.